These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Abigail Alliance v. Von Eschenbach: restricting access to potentially lifesaving drugs singe 2007. Goodman AJ J Contemp Health Law Policy; 2008; 25(1):107-41. PubMed ID: 19137749 [No Abstract] [Full Text] [Related]
25. Immunotherapy: a new option for advanced prostate cancer. Harv Mens Health Watch; 2010 Sep; 15(2):1-2. PubMed ID: 20941869 [No Abstract] [Full Text] [Related]
26. How does sipuleucel-T alter our clinical practice? George D BJU Int; 2010 Oct; 106(7):945-6. PubMed ID: 20931691 [No Abstract] [Full Text] [Related]
27. Sipuleucel-T (APC8015) for prostate cancer. So-Rosillo R; Small EJ Expert Rev Anticancer Ther; 2006 Sep; 6(9):1163-7. PubMed ID: 17020451 [TBL] [Abstract][Full Text] [Related]
28. Is Provenge Angst a symbol or symptom of the times? Holcombe DG Am J Manag Care; 2012 May; 18(3 Spec No.):SP108-9. PubMed ID: 22642274 [No Abstract] [Full Text] [Related]
37. Cancer immunotherapy. White RL; Amin A Surg Oncol Clin N Am; 2011 Jul; 20(3):531-54, ix. PubMed ID: 21640920 [TBL] [Abstract][Full Text] [Related]
38. Approval of provenge seen as first step for cancer treatment vaccines. Brower V J Natl Cancer Inst; 2010 Aug; 102(15):1108-10. PubMed ID: 20668267 [No Abstract] [Full Text] [Related]